Enlivex Therapeutics (Israel) Price on December 2, 2024
ENLV Stock | ILA 415.10 4.10 0.98% |
If you're considering investing in Enlivex Stock, it is important to understand the factors that can impact its price. As of today, the current price of Enlivex Therapeutics stands at 415.10, as last reported on the 2nd of December, with the highest price reaching 425.40 and the lowest price hitting 400.50 during the day. Enlivex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0279, which denotes the company had a -0.0279% return per unit of risk over the last 3 months. Enlivex Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enlivex Therapeutics' Variance of 17.69, standard deviation of 4.21, and Mean Deviation of 2.96 to check the risk estimate we provide.
Enlivex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Enlivex |
Sharpe Ratio = -0.0279
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ENLV |
Estimated Market Risk
4.7 actual daily | 41 59% of assets are more volatile |
Expected Return
-0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Enlivex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enlivex Therapeutics by adding Enlivex Therapeutics to a well-diversified portfolio.
Enlivex Therapeutics Valuation on December 2, 2024
It is possible to determine the worth of Enlivex Therapeutics on a given historical date. On December 2, 2024 Enlivex was worth 419.2 at the beginning of the trading date compared to the closed value of 415.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Enlivex Therapeutics stock. Still, in general, we apply an absolute valuation method to find Enlivex Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enlivex Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Enlivex Therapeutics' related companies.
Open | High | Low | Close | Volume | |
419.20 | 425.40 | 400.50 | 415.10 | 28,522 | |
12/02/2024 | 419.20 | 425.40 | 400.50 | 415.10 | 0.00 |
Backtest Enlivex Therapeutics | | | Enlivex Therapeutics History | | | Enlivex Therapeutics Valuation | Previous |
Enlivex Therapeutics Trading Date Momentum on December 2, 2024
On December 02 2024 Enlivex Therapeutics was traded for 415.10 at the closing time. The highest price during the trading period was 425.40 and the lowest recorded bid was listed for 400.50 . There was no trading activity during the period 0.0. Lack of trading volume on December 2, 2024 did not affect price variability. The overall trading delta to the current price is 0.99% . |
Enlivex Therapeutics Fundamentals Correlations and Trends
By evaluating Enlivex Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Enlivex Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Enlivex financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Enlivex Therapeutics Stock history
Enlivex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enlivex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enlivex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enlivex Therapeutics stock prices may prove useful in developing a viable investing in Enlivex Therapeutics
Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. ENLIVEX THERAPEUTI operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 50 people.
Enlivex Therapeutics Stock Technical Analysis
Enlivex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Enlivex Therapeutics Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Enlivex Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Enlivex Therapeutics December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Enlivex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enlivex Therapeutics shares will generate the highest return on investment. By undertsting and applying Enlivex Therapeutics stock market strength indicators, traders can identify Enlivex Therapeutics entry and exit signals to maximize returns
Enlivex Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Enlivex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Enlivex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enlivex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.17) | |||
Total Risk Alpha | (0.95) | |||
Treynor Ratio | 0.4029 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Enlivex Stock analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |